Dorota Dybowska

Torun, KP 87100, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Potential Drug Interactions in Psychiatric Patients Undergoing Pangenotypic Therapy for Hepatitis C Virus Infection.

Potential Drug Interactions in Psychiatric Patients Undergoing Pangenotypic Therapy for Hepatitis C Virus Infection.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: December 16, 2025

Risk of hepatocellular carcinoma recurrence in liver transplant recipients following treatment of hepatitis C with direct-acting antivirals.

Risk of hepatocellular carcinoma recurrence in liver transplant recipients following treatment of hepatitis C with direct-acting antivirals.

Journal: Polish archives of internal medicine

Published: October 07, 2025

Treatment with Direct-Acting Antivirals in Patients with HCV Infection After Liver Transplantation.

Treatment with Direct-Acting Antivirals in Patients with HCV Infection After Liver Transplantation.

Journal: Journal of clinical medicine

Published: October 06, 2025

Sex-related differences in patients with chronic hepatitis C infection treated with direct-acting antiviral drugs.

Sex-related differences in patients with chronic hepatitis C infection treated with direct-acting antiviral drugs.

Journal: World journal of hepatology

Published: February 10, 2025

Response to therapy with direct antiviral drugs in HCV-infected patients with diabetes.

Response to therapy with direct antiviral drugs in HCV-infected patients with diabetes.

Journal: Scientific reports

Published: December 23, 2024

Treatment of Hepatitis C Virus Infections Among Patients of Ukrainian Origin During the Influx of War Refugees to Poland.

Treatment of Hepatitis C Virus Infections Among Patients of Ukrainian Origin During the Influx of War Refugees to Poland.

Journal: Journal of clinical medicine

Published: October 27, 2024

Hepatitis C Infection Is Not a Cardiovascular Risk Factor in Young Adults.

Hepatitis C Infection Is Not a Cardiovascular Risk Factor in Young Adults.

Journal: Biomedicines

Published: September 28, 2024

The Real-World Efficacy and Safety of Direct-Acting Antivirals for Chronic Hepatitis C in Patients Active Malignancies.

The Real-World Efficacy and Safety of Direct-Acting Antivirals for Chronic Hepatitis C in Patients Active Malignancies.

Journal: Cancers

Published: August 11, 2024

Effectiveness of glecaprevir/pibrentasvir in HIV/HCV-coinfected patients treated with bictegravir/emtricitabine/tenofovir alafenamide.

Effectiveness of glecaprevir/pibrentasvir in HIV/HCV-coinfected patients treated with bictegravir/emtricitabine/tenofovir alafenamide.

Journal: Clinical and experimental hepatology

Published: May 28, 2024

Real-life effectiveness of antiviral therapy for HCV infection with pangenotypic regimens in HIV coinfected patients.

Real-life effectiveness of antiviral therapy for HCV infection with pangenotypic regimens in HIV coinfected patients.

Journal: Expert review of anti-infective therapy

Published: May 09, 2024

Real-world experience with direct-acting antiviral therapy in HCV-infected patients with cirrhosis and esophageal varices.

Real-world experience with direct-acting antiviral therapy in HCV-infected patients with cirrhosis and esophageal varices.

Journal: Pharmacological reports : PR

Published: May 03, 2024

Treatment of HCV infection in patients with steatotic liver disease.

Treatment of HCV infection in patients with steatotic liver disease.

Journal: Clinical and experimental hepatology

Published: April 17, 2024

Showing 1-12 of 53

Last Updated: 09/26/2026